FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum

Human Gene Therapy

Volumn 8, Issue 13, 1997, Pages 1575-1583

  Miyao, Yasuyoshi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMOSTAT MESILATE; COMPLEMENT; COMPLEMENT INHIBITOR; GABEXATE MESILATE; NAFAMSTAT MESILATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EXPRESSION VECTOR; FIBROBLAST; GENE TRANSFER; GUINEA PIG; MOUSE; NONHUMAN; RETROVIRUS; SERUM; SHEEP ERYTHROCYTE; VIRUS INACTIVATION;

ANIMALIA; CAVIA PORCELLUS; OVIS ARIES; SUS SCROFA; UNIDENTIFIED RETROVIRUS;

EID: 0030708921     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.13-1575     Document Type: Article

References (1)

1. COOPER, N.R., JENSEN, F., RAYMOND, M.W., and OLDSTONE, M.B.A. (1976). Lysis of RNA tumor viruses by human serum; Direct antibody-independent triggering of the classical complement pathway. J. Exp. Med. 144, 970-984.